Talphera, Inc. (TLPH) News
Follow Talphera, Inc. (TLPH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
TLPH: Pivotal nafamostat study nears completion, targeting U.S. approval and strong market adoption
Three major catalysts are expected in the next year, including a pivotal study readout for nafamostat in CRRT, with approval targeted for the second half of next year. The study is highly powered with objective endpoints
NEWS | Sep 14, 2026, 09:34 PM UTC
L
TLPH: Nafamostat's pivotal CRRT study nears completion, with strong market and guideline support
Pivotal study for nafamostat in CRRT anticoagulation is nearing completion, with top-line data expected by year-end and a PMA filing planned soon after. Updated market analysis shows a larger, growing opportunity, and re
NEWS | Sep 14, 2026, 09:20 PM UTC
L
TLPH - Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
TLPH - Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 03, 2026, 12:31 PM UTC
L
Talphera Announces Q2 2026 Financial Results
Talphera announces second quarter 2026 financial results and provides corporate update
EARNINGS | Aug 12, 2026, 08:06 PM UTC
L
TLPH TLPH TLPH - Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
TLPH TLPH TLPH - Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
EARNINGS | Aug 05, 2026, 08:06 PM UTC